Viropil (Dolutegravir Lamivudine Tenofovir Disoproxil Fumarate Tablet) 50mg/300mg/300mg

Viropil (Dolutegravir Lamivudine Tenofovir Disoproxil Fumarate) is a fixed-dose antiretroviral tablet used in HIV management. It combines three active ingredients to support viral suppression. This medication is prescribed as part of a complete treatment regimen. Always follow healthcare provider guidance when using antiretrovirals.

Strength

50mg/300mg/300mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Emcure Pharmaceuticals Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Viropil is used to treat HIV-1 infection in adults and adolescents weighing at least 40 kg. It combines dolutegravir, lamivudine, and tenofovir disoproxil fumarate to reduce viral load. This fixed-dose combination supports consistent adherence to therapy. It is not a cure for HIV but helps manage the condition when taken as directed.

Side Effects

Viropil may help reduce HIV-related symptoms and improve immune function over time. Some users report better energy levels and fewer opportunistic infections. Regular monitoring is recommended to assess treatment progress. Individual responses can vary based on health status and adherence.

Precautions & Warnings

Store Viropil at room temperature away from moisture and heat. Keep out of reach of children and pets. Do not use if the seal is broken or the tablet is damaged. Inform your healthcare provider about all current medications and health conditions before starting this treatment.

Avoid Interactions

Viropil may interact with other antiretroviral drugs or medications that affect kidney function. Avoid alcohol as it may increase side effects or reduce effectiveness. Some supplements and herbal products may also interact; consult your doctor before combining therapies. CYP3A inducers like rifampin can lower dolutegravir levels.

References

Frequently Asked Questions

Viropil is used to treat HIV-1 infection in adults and adolescents weighing at least 40 kg as part of antiretroviral therapy.

Store Viropil at room temperature, away from moisture and heat, and keep it out of reach of children.

Consult your healthcare provider before taking Viropil with other drugs, as interactions may occur with certain antiretrovirals or supplements.

Viropil is not a cure for HIV but helps manage the infection by reducing viral load when taken as prescribed.

If you miss a dose, take it as soon as you remember unless it is almost time for the next dose; do not double up on doses.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.